Gensight Biologics SA
PAR:SIGHT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.29
0.704
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Gensight Biologics SA
Other Current Liabilities
Gensight Biologics SA
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gensight Biologics SA
PAR:SIGHT
|
Other Current Liabilities
€462k
|
CAGR 3-Years
-51%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Valneva SE
PAR:VLA
|
Other Current Liabilities
€29.9m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
19%
|
CAGR 10-Years
21%
|
|
Nanobiotix SA
PAR:NANO
|
Other Current Liabilities
€37.9m
|
CAGR 3-Years
67%
|
CAGR 5-Years
54%
|
CAGR 10-Years
44%
|
|
Innate Pharma SA
PAR:IPH
|
Other Current Liabilities
€3.2m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
12%
|
|
Genfit SA
NASDAQ:GNFT
|
Other Current Liabilities
€15.9m
|
CAGR 3-Years
103%
|
CAGR 5-Years
100%
|
CAGR 10-Years
17%
|
|
Eurobio Scientific SA
PAR:ALERS
|
Other Current Liabilities
€18.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
24%
|
CAGR 10-Years
23%
|
See Also
What is Gensight Biologics SA's Other Current Liabilities?
Other Current Liabilities
462k
EUR
Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Other Current Liabilities amounts to 462k EUR.
What is Gensight Biologics SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
39%
Over the last year, the Other Current Liabilities growth was -39%. The average annual Other Current Liabilities growth rates for Gensight Biologics SA have been -51% over the past three years , 39% over the past five years .